About starling oncology inc - STLN
Starling Oncology, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
STLN At a Glance
Starling Oncology, Inc.
18000 Studebaker Road
Cerritos, California 90703
| Phone | 1-562-735-3226 | Revenue | 502.73M | |
| Industry | Medical/Nursing Services | Net Income | -50,305,000.00 | |
| Sector | Health Services | 2025 Sales Growth | 27.787% | |
| Fiscal Year-end | 12 / 2026 | Employees | 641 | |
| View SEC Filings |
STLN Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.654 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -13.696 |
| Enterprise Value to Sales | 0.794 |
| Total Debt to Enterprise Value | 0.26 |
STLN Efficiency
| Revenue/Employee | 784,288.612 |
| Income Per Employee | -78,478.939 |
| Receivables Turnover | 8.475 |
| Total Asset Turnover | 2.838 |
STLN Liquidity
| Current Ratio | 1.589 |
| Quick Ratio | 1.351 |
| Cash Ratio | 0.473 |
STLN Profitability
| Gross Margin | 13.823 |
| Operating Margin | -7.177 |
| Pretax Margin | -12.081 |
| Net Margin | -10.006 |
| Return on Assets | -28.395 |
| Return on Equity | N/A |
| Return on Total Capital | -57.145 |
| Return on Invested Capital | -50.093 |
STLN Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 117.857 |
| Total Debt to Total Assets | 60.172 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 109.687 |